Artemis Medicare Services Ltd. (ARTEMISMED): Artemis Medicare Services 52 Week High Streak: Second Straight Session at Fresh Yearly Peak

Artemis Medicare Services Ltd. (ARTEMISMED) has now set a fresh 52-week high for its second straight session, extending a 4.13% cumulative move across the streak. The latest peak stood at Rs 338.7, while the stock last traded at Rs 333. The latest Univest data confirms the repeated-high pattern, but it does not establish a company-specific catalyst for the continued move.

As of 07 September 2026 at 9:52 AM IST, the stock had opened at Rs 338.7, touched a low of Rs 332.45 and was trading near Rs 333 versus the previous close of Rs 332.7. Turnover stood at Rs 0.45 crore and market capitalisation at Rs 5,266.85 crore. For readers, a repeated 52-week high streak is more informative than a single-day breakout because it shows the price keeping pace with the new yearly peak across more than one session.

Artemis Medicare Services 52 Week High Streak: Consecutive High Analysis

Metric	Value
Current Price	Rs 333
Previous Close	Rs 332.7
Today's Move	+Rs 0.3 (+0.09%)
Open	Rs 338.7
High	Rs 338.7
Low	Rs 332.45
Turnover	Rs 0.45 crore
Market Capitalisation	Rs 5,266.85 crore

Artemis Medicare Services Ltd. (ARTEMISMED) traded at Rs 333 versus the previous close of Rs 332.7, a rise of 0.09%. The stock opened at Rs 338.7, reached a high of Rs 338.7 and touched a low of Rs 332.45.

ARTEMISMED was trading at Rs 333, up Rs 0.3 or 0.09% from the previous close of Rs 332.7. The stock moved within a tight band after opening at Rs 338.7, matching the day’s high, while the low was Rs 332.45. That places the current price closer to the lower end of the day’s range than the peak, even though the stock has already printed a fresh 52-week high for the second straight session.

The key point in the share price today picture is not the small intraday change alone, but the fact that the repeated one-year high pattern has held. Turnover was Rs 0.45 crore, and the market cap was Rs 5,266.85 crore, which places the stock in the middle of the healthcare universe by size rather than at the extremes. The current setup matters because the latest high is not just a one-off print; it is part of a two-session extension in ARTEMISMED share price action.

What the Repeated 52-Week Highs Show

The repeated highs show that ARTEMISMED has stayed at or near its fresh yearly peak across consecutive trading sessions, with the current 52-week high at Rs 338.7 and the cumulative streak move at 4.13%. That is the most important read from the streak analysis: the stock has not simply touched a new one-year high once, but has remained in that zone for a second straight session.

The latest data also gives a clean comparison point for the move. The current 52-week high is Rs 338.7, and the stock last traded at Rs 333, showing that the price remains close to the peak rather than far below it. At the same time, the figures do not establish why the pattern is continuing. There is no company-specific catalyst confirmed by the numbers alone, so the correct interpretation is to treat this as a price pattern that is visible, but not explained, by the latest market data.

Artemis Medicare Services Ltd. (ARTEMISMED) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 5,266.85 crore
P/E Ratio	46.34x
P/B Ratio	5.87x
ROE	12.72%
ROCE	15.83%
EPS	Rs 7.18
Book Value Per Share	Rs 56.68
Dividend Yield	0.14%

Artemis Medicare Services Ltd. (ARTEMISMED) fundamental metrics show P/E 46.34x, P/B 5.87x, ROE 12.72%, ROCE 15.83%. These figures provide context only and are not a buy or sell signal.

Artemis Medicare Services Ltd. has a market capitalisation of Rs 5266.85 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 46.34x, P/B at 5.87x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 12.72% and ROCE of 15.83%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 7.18, book value per share of Rs 56.68, dividend yield of 0.14%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 46.55x, median ROE of 12.82%, median ROCE of 14.97%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Hospital & Healthcare Services
Benchmark Scope	same industry
Company P/E Ratio	46.34x
Benchmark Median P/E	46.55x
Benchmark Average P/E	102.61x
Benchmark P/E Range	7.87x to 1,488.32x
Company P/B Ratio	5.87x
Benchmark Median P/B	3.04x
Company ROE	12.72%
Benchmark Median ROE	12.82%
Company ROCE	15.83%
Benchmark Median ROCE	14.97%
Company Market Capitalisation	Rs 5,266.85 crore
Benchmark Median Market Cap	Rs 517.16 crore

Artemis Medicare Services Ltd. (ARTEMISMED) is classified under sector: Healthcare and industry: Hospital & Healthcare Services.

Artemis Medicare Services Ltd. (ARTEMISMED) has a P/E ratio of 46.34x, which is below the benchmark median of 46.55x, a difference of -0.45%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Artemis Medicare Services Ltd. (ARTEMISMED) has a ROE of 12.72%, which is below the benchmark median of 12.82%, a difference of -0.78%. Artemis Medicare Services Ltd. (ARTEMISMED) has a ROCE of 15.83%, which is above the benchmark median of 14.97%, a difference of +5.74%.

Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Kovai Medical Center & Hospital Ltd.	KOVAI	6,623.9	25.84	4.77	20.33	22.89
NEPHROCARE HEALTH SERV L	NEPHROPLUS	7,012.48	91.26	6.18	9.22	16.18
Indraprastha Medical Corporation Ltd.	INDRAMEDCO	3,209.93	17.07	4.03	27.47	37.7
Thyrocare Technologies Ltd.	THYROCARE	9,170.31	52.02	14.57	29.05	38.3
Jupiter Life Line Hospitals Ltd.	JLHL	9,387.42	50.04	5.94	13.39	15.7

Artemis Medicare Services Ltd. (ARTEMISMED) has a P/E ratio of 46.34x compared with the displayed peer median of 50.04x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 12.72% compares with a peer median of 20.33% across the companies shown in the table. ROCE stood at 15.83% versus the displayed peer median of 22.89%, providing a capital-efficiency comparison. Artemis Medicare Services Ltd. (ARTEMISMED) has a market capitalisation of Rs 5,266.85 crore. Among the 5 peers shown, 4 have a larger market capitalisation.

Why Investors Are Watching Artemis Medicare Services

• ARTEMISMED has now set a fresh 52-week high for its second straight session.
• The cumulative move across the streak stands at 4.13%.
• The latest high of Rs 338.7 is the current reference point for the move.
• P/E at 46.34 is close to the healthcare industry median of 46.55.
• P/B at 5.87 is higher than the industry median of 3.04.

About Artemis Medicare Services

Artemis Medicare Services Ltd. operates in the Healthcare sector under the Hospital & Healthcare Services industry. The company has a market capitalisation of Rs 5,266.85 crore, and its latest reported financial ratios show EPS of Rs 7.18, book value of Rs 56.68, ROE of 12.72% and ROCE of 15.83%. Those figures provide the base context for reading the recent 52-week high streak.

The company’s share price update should be viewed in relation to both its financial profile and the latest market range. ARTEMISMED is trading in a valuation band that sits close to the industry earnings median, while its book valuation is higher than the sector midpoint. For readers scanning the stock news flow, that is the core backdrop to keep in mind when reviewing the repeated yearly high.

Track Artemis Medicare Services on Univest

Keep watching ARTEMISMED share price today, the next market update and any fresh move around the 52 week high stocks universe. You can follow Artemis Medicare Services Ltd. on Univest for ongoing stock performance coverage, market cap tracking and company news in one place.

Frequently Asked Questions

What does ARTEMISMED’s 52 week high streak mean?

Ans. It means Artemis Medicare Services has set a fresh 52-week high for a second straight session. The pattern shows the stock remaining at a new yearly peak across consecutive trading sessions, with the latest peak at Rs 338.7.

How many sessions has ARTEMISMED been at a fresh 52-week high?

Ans. The stock has set a fresh 52-week high for two consecutive sessions. That is the current streak length, and the cumulative move across those sessions is 4.13%. The stock moved 0.09% so far today.

What is the latest 52-week high for ARTEMISMED?

Ans. The latest 52-week high recorded for ARTEMISMED is Rs 338.7. The stock last traded at Rs 333 as of 07 September 2026 at 9:52 AM IST. The stock moved 0.09% so far today.

What does the repeated yearly high suggest for investors?

Ans. It shows that the stock has continued to trade near its fresh annual peak over more than one session. That is useful for tracking the pattern, even though the latest numbers do not identify a specific catalyst.

How does ARTEMISMED compare with healthcare peers on valuation?

Ans. Its P/E of 46.34 is close to the industry median of 46.55, while its P/B of 5.87 is above the industry median of 3.04. That places it in the middle on earnings and richer on book value.

What should investors monitor next in ARTEMISMED?

Ans. Investors can monitor whether the stock remains near the Rs 338.7 peak, how the share price behaves relative to the previous close, and whether the valuation picture stays in line with healthcare peers.

Is ARTEMISMED an all-time high stock?

Ans. This update confirms a fresh 52-week high, not an all-time high. An all-time high should be mentioned only when that specific record is explicitly supported by the latest figures.

Why is ARTEMISMED still hitting 52-week highs?

Ans. The latest numbers confirm the streak, but they do not establish a company-specific reason for it. The factual takeaway is that ARTEMISMED has repeated a new yearly high across two sessions.

Track Artemis Medicare Services Ltd. (ARTEMISMED) Share Price on Univest

Use Artemis Medicare Services Ltd. (ARTEMISMED) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.